Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases

被引：8
作者：
Armandi, Angelo [1 ]
Bugianesi, Elisabetta [1 ]
机构：
[1] Univ Turin, Dept Med Sci, Corso Dogliotti 14, I-10126 Turin, Italy
来源：
CLINICS IN LIVER DISEASE | 2023年 / 27卷 / 02期
关键词：
NAFLD; Cardiovascular disease; Coronary artery disease; Atherosclerosis; Cardiac remodeling; Heart failure; Gene polymorphisms; Gut dysbiosis; TRIMETHYLAMINE-N-OXIDE; INSULIN-RESISTANCE; METABOLIC SYNDROME; FIBROSIS STAGE; HEART-DISEASE; RISK; ASSOCIATION; DYSFUNCTION; MORTALITY; ATHEROSCLEROSIS;
D O I：
10.1016/j.cld.2023.01.018
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
In conclusion, the strong association between NAFLD and CVD demands a compre-hensive evaluation of metabolic dysfunctions in multiple districts. Cardiovascular health represents the main target of screening strategies to prevent adverse outcomes in the NAFLD population. Improved referral policies and the development of shared pathways of management will help reduce the burden of cardiovascular mortality in this population.
引用
收藏
页码：239 / 250
页数：12
相关论文
共 57 条
[1]   Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults [J].
Alexander, Myriam ;
Loomis, A. Katrina ;
van der Lei, Johan ;
Duarte-Salles, Talita ;
Prieto-Alhambra, Daniel ;
Ansell, David ;
Pasqua, Alessandro ;
Lapi, Francesco ;
Rijnbeek, Peter ;
Mosseveld, Mees ;
Avillach, Paul ;
Egger, Peter ;
Dhalwani, Nafeesa N. ;
Kendrick, Stuart ;
Celis-Morales, Carlos ;
Waterworth, Dawn M. ;
Alazawi, William ;
Sattar, Naveed .
BMJ-BRITISH MEDICAL JOURNAL, 2019, 367
[2]   Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease [J].
Anand, SS ;
Yi, QL ;
Gerstein, H ;
Lonn, E ;
Jacobs, R ;
Vuksan, V ;
Teo, K ;
Davis, B ;
Montague, P ;
Yusuf, S .
CIRCULATION, 2003, 108 (04) :420-425
[3]   Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease [J].
Anstee, Quentin M. ;
Mantovani, Alessandro ;
Tilg, Herbert ;
Targher, Giovanni .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (07) :425-439
[4]   Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches [J].
Armandi, Angelo ;
Schattenberg, Jorn M. .
NUTRIENTS, 2021, 13 (06)
[5]   Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease [J].
Armandi, Angelo ;
Rosso, Chiara ;
Caviglia, Gian Paolo ;
Bugianesi, Elisabetta .
METABOLITES, 2021, 11 (03)
[6]   Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality [J].
Brouwers, Martijn C. G. J. ;
Simons, Nynke ;
Stehouwer, Coen D. A. ;
Isaacs, Aaron .
DIABETOLOGIA, 2020, 63 (02) :253-260
[7]   A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease [J].
Caussy, Cyrielle ;
Tripathi, Anupriya ;
Humphrey, Greg ;
Bassirian, Shirin ;
Singh, Seema ;
Faulkner, Claire ;
Bettencourt, Ricki ;
Rizo, Emily ;
Richards, Lisa ;
Xu, Zhenjiang Z. ;
Downes, Michael R. ;
Evans, Ronald M. ;
Brenner, David A. ;
Sirlin, Claude B. ;
Knight, Rob ;
Loomba, Rohit .
NATURE COMMUNICATIONS, 2019, 10 (1)
[8]   Associations of gut-floradependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults [J].
Chen, Yu-ming ;
Liu, Yan ;
Zhou, Rui-fen ;
Chen, Xiao-ling ;
Wang, Cheng ;
Tan, Xu-ying ;
Wang, Li-jun ;
Zheng, Rui-dan ;
Zhang, Hong-wei ;
Ling, Wen-hua ;
Zhu, Hui-lian .
SCIENTIFIC REPORTS, 2016, 6
[9]  
EASL, 2016, OBESITY FACTS, V9, P65, DOI [10.1159/000443344, 10.1007/s00125-016-3902-y, 10.1016/j.jhep.2015.11.004]
[10]   Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up [J].
Ekstedt, Mattias ;
Hagstrom, Hannes ;
Nasr, Patrik ;
Fredrikson, Mats ;
Stal, Per ;
Kechagias, Stergios ;
Hultcrantz, Rolf .
HEPATOLOGY, 2015, 61 (05) :1547-1554
123456